Syndax Pharmaceuticals, Inc. (SNDX)
20.54
-0.12
(-0.56%)
USD |
NASDAQ |
May 07, 16:00
20.54
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Research and Development Expense (Annual) : 258.78M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Cogent Biosciences, Inc. | 265.16M |
| Vera Therapeutics, Inc. | 214.79M |
| Biogen, Inc. | 1.481B |
| Stryker Corp. | 1.567B |
| Corcept Therapeutics, Inc. | 254.91M |